LP Pharma raises $72m Series C funding led by Sequoia Capital China

LP Pharma raises $72m Series C funding led by Sequoia Capital China

Photo: Pixabay

LP Pharmaceuticals (Xiamen) Co., Ltd has raised 500 million yuan ($72 million) in Series C funding led by Sequoia Capital China, according to a company statement on Wednesday.